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Background: Spinal cord ischemia reperfusion (IR) injury causes inflammation and subsequently increases blood-spinal
cord barrier leakage and Toll-like receptor 4 (TLR4) pathway activation. MicroRNAs (miRs) effectively regulate numerous
target mRNAs during ischemia. However, their roles during IR injury are poorly understood. We investigated miRs
involvement, particularly miR-27a, in TLR4 pathway-mediated inflammatory responses after IR.
Method: We used a genomics approach to examine changed miRs of rats that had undergone 14 minutes of
ischemia, followed by 24 or 72 hours of reperfusion. Quantitative RT-PCR was used to identify and confirm the
miRs involved in regulating TLR4 pathway activation. We scanned miR databases for potential miR targets and confirmed
these targets by quantitative RT-PCR. The miR mimic and anti-miR oligonucleotides (AMOs) were intrathecally injected at
12-hour intervals beginning three days before the ischemia. The effects of miRs on the TLR4 pathway and downstream
cytokines were analyzed by PCR, western blotting, and ELISA. Double immunofluorescence staining was perfumed to
determine the relationship between the targets and TLR4. Blood-spinal cord barrier (BSCB) permeability was examined
using Evans blue (EB) dye.
Results: A microarray analysis revealed that at 24 hours post-injury, three miRs were upregulated (>2.0 fold) and 15 miRs
were downregulated (<0.5 fold), and at 72 hours, four miRs were upregulated and 14 were downregulated compared to
their levels in sham-operated controls. We focused on miR-27a, which is predicted to contain sequences complementary
to the 3'-untranslated region (UTR) of Toll-like receptor adaptor molecule 2 (TICAM-2). Double immunostaining indicated
that TLR4 activation correlated with changes in TICAM-2 expression. Compared to the rats in the IR and negative control
groups, intrathecal infusion of the miR-27a mimic attenuated IR-induced TLR4 activation and inflammatory damage to
the BSCB, which was shown as decreased EB extravasation and lower levels of nuclear factor kappa-B (NF-κB) and
lnterleukin (IL)-1β at 24 and 72 hours after reperfusion, whereas pretreatment with miR-27a AMO aggravated
these injuries.
Conclusions: We present the first evidence that miRs play an important role in spinal cord IR injury. We identified
TICAM-2 as a novel target of miR-27a. miR-27a upregulation attenuates IR-induced inflammatory damage to the
BSCB by negatively regulating TICAM-2 of the TLR4 signaling pathway and inhibiting the NF-κB/IL-1β pathway.
These results provide new therapeutic targets for IR injury treatment.
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Spinal cord ischemia reperfusion (IR) injuries have gar-
nered much attention since 1986, when an IR injury was
first reported, as they are associated with severe compli-
cations such as bladder, bowel, sexual dysfunction, and
paraplegia [1]. Spinal cord IR injuries can induce a cas-
cade of secondary events, such as neuronal or glial insults,
that lead to further cell loss and behavioral impairments.
These, in turn, are closely associated with inflammatory re-
sponses, including the release of cytokines, chemokines,
and the recruitment of immune cells [2-4]. Numerous
studies have shown that the major effectors involved in
this inflammatory cascade activate the Toll-like recep-
tors (TLRs), and the neuroprotective effect of inhibiting
the TLR4 inflammatory pathway has been extensively
studied by us and others [5-8].
We previously demonstrated that intrathecal antagonism
of TLR4 in a rat model of IR, induced by transient occlu-
sion of the aortic arch, could maintain the integrity of the
blood-spinal cord barrier (BSCB) and attenuate secondary
spinal cord injury by inhibiting proinflammatory cytokines,
molecules downstream of the TLR4 pathway [6,7]. Con-
trary to previous investigations that showed that Myeloid
differentiation factor88 (MyD88) and MyD88 adaptor-like
(Mal/TIRAP) adaptors functioned downstream of TLR4,
the adapter TIR-containing adaptor molecule-2 (TICAM-
2, also known as TRAM) was shown to resemble Mal/
TIRAP and to physically bridge it with TICAM-1 to func-
tionally transmit the TLR4 signal [9,10]. Therefore, TLR4
recruits two crucial adaptors, TIRAP and TICAM-2, which
are connected to two effective adapters, MyD88 and
TICAM-1, respectively, after activation [9].
MicroRNAs (miRs) are small, non-coding RNAs that are
capable of specific binding to one or more target mRNAs,
and effectively regulate their post-transcriptional expression
in various tissues [11-13]. Studies have shown that several
miRs can dramatically alter normal physiological processes
and are involved in the pathogenesis of various diseases
[14,15]. Recent studies showed that ischemia alters the ex-
pression of miRs in cardiac tissue, and antagomirs against
miRs improved neovascularization and augmented func-
tional recovery in a large animal model of cardiac IR injury,
suggesting a role for miRs in the regulation of IR [16,17].
Furthermore, there is also increasing evidence for the in-
volvement of miRs in traumatic spinal cord injury [18,19].
However, the role of miRs in IR is not well understood.
Exploring the expression profiles of miRs altered after IR
might reveal whether miR-dependent post-transcriptional
gene regulation in TLR4-mediated inflammation deter-
mines the progression of, and recovery from, secondary
damage to the spinal cord.
In this study, we first used miR arrays to determine
the expression patterns of miRs in a rat model of spinal
cord IR injury, and then identified their target mRNAs bysearching the TargetScan, MicroCosm Targets (version 5),
and microRNA.org databases. Among the miRs identified,
we observed that miR-27a was one of the most dysregu-
lated miRs, and further defined TICAM-2, a key regulator
of the TLR4 pathway, as its target. Then, the effects of
miR-27a were assessed in a rat model of IR by intrathecal
pretreatment with an miR mimic and an anti-miR oligo-
nucleotide (AMO) starting three days before ischemia.
Our results demonstrated that increasing the expres-
sion of miR-27a attenuated IR-induced spinal cord
injury by negatively modulating the TLR4 signaling
regulator TICAM-2, which may be a new therapeutic
target under neuroinflammatory conditions.
Materials and methods
Experimental animals
The experimental procedures were performed in accordance
with the Guide for the Care and Use of Laboratory Animals
(United States National Institutes of Health publication
number 85–23, National Academy Press, Washington DC,
revised 1996) The animals used in this study were male
Sprague-Dawley rats (obtained from Animal center of China
Medical University, Shenyang, China) weighing between 200
and 250 g. The rats were bred in standard cages with
free access to food and water, and were housed separately
after surgery at First Affiliated Hospital of China Medical
University.
Rat model of spinal cord ischemia reperfusion injury
To establish the spinal cord IR model, IR was induced by
occluding the aortic arch for 14 minutes, as previously
reported [6,7]. In brief, rats were anesthetized with an intra-
peritoneal injection of 4% sodium pentobarbital (Beyotime
Biotechnology, Shanghai, China) at a dose of 50 mg/kg, and
then the aortic arch was exposed through a cervicothoracic
approach. Under direct visualization, the aortic arch was
cross-clamped between the left common carotid artery and
left subclavian artery. Occlusion was confirmed with a laser
Doppler blood flow monitor (Moor Instruments, Axminster,
Devon, United Kingdom). Ischemia, which is defined as a
90% decrease in the flow measured at the femoral ar-
tery{AU Query: If this definition originates from any
official published guidelines, please provide a refer-
ence}, continued for 14 minutes, after which the clamps
were removed and reperfusion was allowed to continue for
either 24 or 72 hours. Sham-operated rats underwent the
same procedure without aortic arch occlusion.
MiR microarray analysis
To assess MiR expression in the spine, L4–6 segments of
the spinal cord were harvested at 24 and 72 hours after re-
perfusion, frozen in liquid nitrogen, and stored at −80°C
until use. Total RNA was isolated from the samples using
TRIzol® reagent (Invitrogen, Carlsbad, California, United
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United Kingdom) according to the manufacturers’ instruc-
tions. After measuring the quantity of RNA using a Nano-
Drop 1000 (Youpu Scientific Instrument Co., Ltd., Shanghai,
China), the samples were labeled using the miRCURY™
Hy3™/Hy5™ Power labeling kit (Exiqon, Vedbaek, Denmark)
and hybridized on a miRCURY™ LNA Array (version 18.0,
Exiqon, Vedbaek, Denmark). After washing, the slides were
scanned using an Axon GenePix 4000B microarray scanner
(Axon Instruments, Foster City, California, United States).
Scanned images were then imported into the GenePix Pro
6.0 program (Axon Instruments) for grid alignment and data
extraction. Replicated miRs were averaged, and miRs withFigure 1 Hierarchical cluster analyses of altered microRNAs (miRs) aft
expressed miRs in the sham-operated and IR groups at 24 hours post-inju
sham-operated and IR groups at 72 hours post-injury (n = three per group
The color code shown at the bottom of the heat maps is linear, with gree
are shown in green to red, whereas the miRs that were downregulated are sh
miR-27a was the most significantly downregulated in injured spinal cords at tintensities of 50 or more in all samples were used to calcu-
late a normalization factor. Expressed data were normalized
by median normalization. After normalization, the miRs that
were significantly differentially expressed were identified by
Volcano Plot filtering. Finally, hierarchical clustering
was performed to determine the differences in the miR
expression profiles among the samples by using MEV
software (version 4.6; TIGR, Microarray Software Suite
4, Boston, United States).
Measurement of Evans blue extravasation
After 24 and 72 hours of reperfusion, Evans blue dye
((EB) 30 g/L; Sigma-Aldrich, Louis, United States) waser spinal cord ischemia reperfusion (IR) injury. (a) Differentially
ry (n = three per group). (b) Differentially expressed miRs in the
).Each row represents an miR and each column represents a sample.
n as the lowest and red as the highest. The miRs that were upregulated
own from red to green. Among all the significantly changed miRs,
he abovementioned time points.
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60 minutes before the animals were euthanized. After
adequate perfusion with saline under deep anesthesia,
the L4–6 segments were removed, soaked in methana-
mide (Beyotime Biotechnology, Shanghai, China) for
24 hours at 60°C, and then centrifuged. EB content was
measured as the absorbance of the supernatant at
632 nm on a microplate reader (BioTek, Winooski,
Vermont, United States) and is reported as the amount
of EB per wet tissue weight (μg/g). To measure the
fluorescence, the tissue was fixed in 4% paraformalde-
hyde (Beyotime Biotechnology, Shanghai, China), sec-
tioned (10 μm), sealed in a light-tight container, and
frozen. EB staining was visualized using a BX-60 fluores-
cence microscope (Olympus, Melville, New York, United
States) with a green filter.
Quantification of miR expression
MiR expression was quantified by using an Applied Biosys-
tems 7500 Real-Time PCR System (Foster City, California,
United States) to verify regulation of the miR targets in the
spinal segments of the IR and sham groups. Total RNA
from the L4–6 segments of the spinal cords was extracted
with TRIzol reagent and reverse transcribed to cDNA withTable 1 MicroRNAs (miRs) that were differentially expressed i
reperfusion (IR) injury compared with sham-operated rats (n
Average intensity of all probes (normalized)





















Only the miRs with fold changes that were significantly different (upregulated >2.0
##: amiRs that were differentially expressed in the spinal cord at both 24 and 72 hothe PrimeScript® miRNA cDNA synthesis kit (Perfect Real
Time; TaKaRa, Dalian, China) according to the manufac-
turers’ instructions. PCR was then used to amplify
miR-27a using SYBR Premix Ex TaqTM II (Perfect
Real Time; TaKaRa, Tokyo, Japan) and miR-27a-spe-
cific primers (forward, 5′-ACACTCCAGCTGGGTTCA-
CAGTGGCTAAG-3′ and reverse, 5′-TGGTGTCGTG
GAGTCG-3′; RiboBio, Guangzhou, China) at 95°C for
10 seconds, followed by 40 cycles of 95°C for five seconds
and 60°C for 20 seconds. The primers used to amplify U6
were 5′-CTCGCTTCGGCAGCACA-3′ (forward) and
5′-AACGCTTCACGAATTTGCGT-3′ (reverse). All reac-
tions were performed in triplicate. The relative expression
of miR-27a was normalized to U6. Data were analyzed by
using the 2−ΔΔCt method.
Intrathecal pretreatment with a synthetic miR mimic and
an anti-miR oligonucleotide
The method used to pretreat rats with a mimic and an
AMO of miRNA-27a (GenBank number: [NR_031833.1])
and negative controls has been previously described [17].
For intrathecal infusion, a laminectomy was performed at
the level of the thoracic vertebrae under pentobarbital
anesthesia (Beyotime Biotechnology, Shanghai, China).n the spinal cord of rats 24 hours after ischemia
= three per group)
Standard deviation
IR-24 hours Sham-24 hours Fold change P value
0.7156 0.3879 3.5766 0.0460
0.4047 0.8048 4.7460 0.1664
0.1434 0.7703 8.1081 0.1200
0.2746 1.2941 0.3053 0.0667
0.0362 0.7307 0.4101 0.0276
0.0362 1.1760 0.4504 0.1449
0.0380 1.2318 0.3164 0.0390
0.1440 1.1157 0.3213 0.0383
0.1272 0.2713 0.4954 0.0140
0.0403 1.0331 0.3777 0.0515
0.1480 0.8460 0.3901 0.0433
0.0886 0.4960 0.4919 0.0389
0.0651 0.8409 0.4331 0.0567
0.0318 0.8743 0.4918 0.1107
0.1642 1.0404 0.3634 0.0162
0.1408 0.5557 0.4959 0.1241
0.1617 0.6810 0.4293 0.0415
0.2262 1.3509 0.3969 0.1642
fold or downregulated <0.5 fold; P < 0.05) are shown.
urs after IR.
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Kingdom, inside diameter (ID): 0.28 mm and outside
diameter (OD): 0.61 mm) was passed caudally from T9–12,
and 2 cm of the free end was left exposed in the upper
thoracic region. We intrathecally infused 100 μL of a syn-
thetic miR-27a mimic (mimic-27a), an AMO (AMO-27a),
or the negative control (NC-27a, all at 50 mg/kg; Jima
Inc., Shanghai, China) pretreated with Lipofectamine®
2000 (Invitrogen) continuously for three days before
the surgical operation. The sequences of mimic-27a,
AMO-27a, and NC-27a were 5′-UUCACAGUGGCUA
AGUUCCGC-3′, 5′-GCGGAACTTAGCCACTGTGAA-
3′, and 5′-AAGGCAAGCUGACCCUGAAGUU-3′, re-
spectively. To analyze the specificity and efficacy of the
miR-27a and AMO-27a, real-time PCR was performed as
described above.
Quantification of TLR4 and TICAM-2 mRNA
Quantitative real-time PCR was used to detect TLR4 and
TICAM-2 mRNA as previously described [7]. Total RNA
was extracted from L4–6 spinal cord tissue using TRIzol re-
agent according to the manufacturer’s instructions. PCR
was performed as described previously using SYBR Green
SuperMix-UDG on a Prism 7000 Sequence DetectionTable 2 MicroRNAs (miRs) that were differentially expressed i
reperfusion (IR) injury compared with that in the sham-opera
Average intensity of all probes (normalized)





















Only the miRs with fold changes that were significantly different (upregulated >2.0
a##: miRs that were differentially expressed in the spinal cord at both 24 and 72 hoSystem (Applied Biosystems) and the following primers:
TLR4 (NM_0191178) forward, 5′-GGATGATGCCTCTCT
TGCAT-3′ and reverse, 5′-TGATCCATGCATTGGTAGG
TAA-3′; TICAM-2 (NM_021649) forward, 5′-GGGAATT-
CATAATGGGTATCGGGAAGTC-3′ and reverse, 5′-GG
CTGCAGGTTATATGTTTCATCTCAGGC-3′; and GAP
DH (glyceraldehyde-3-phosphate dehydrogenase, NM_02
3964) forward, 5′-AGAAGGCTGGGGCTCATTTG-3′ and
reverse, 5′-AGGGGCCATCCACAGTCTTC-3′. Amplifica-
tion was performed using the following cycling conditions:
50°C for two minutes (uracil-DNA glycosylase incubation),
95°C for 10 minutes, and 40 cycles of denaturation at 95°C
for 15 seconds and annealing at 60°C for 30 seconds. All
reactions were performed in triplicate. Gene expression was
normalized to GAPDH (as an internal control). Data were
analyzed by using the 2-ΔΔCt method.
Double immunofluorescence staining for TLR4 and
TICAM-2
Double immunofluorescence staining was performed as
described previously to explore the interaction between
TLR4 and TICAM-2 after IR [6,7]. Briefly, 10-μm-thick
sections were incubated with a primary rabbit anti-TLR4
antibody (1:800; Abcam, Cambridge, United States) andn the spinal cord of rats 72 hours after ischemia
ted rats (n = three per group)
Standard deviation
IR-72 hours Sham-72 hours Fold change P value
0.3912 0.2997 4.1246 0.0139
0.0982 0.2326 2.1179 0.0390
0.0599 0.2500 4.1709 0.0201
0.1433 0.6803 3.1259 0.1591
0.1390 0.0936 0.4957 0.0076
0.0362 0.7307 0.3523 0.0276
1.5856 0.7777 0.4905 0.0206
0.1144 0.1230 0.4548 0.0017
0.1440 0.0352 0.4316 0.0024
0.0852 0.0306 0.4939 0.0020
0.2538 0.5311 0.4201 0.0410
0.3002 0.1005 0.4102 0.0206
0.0650 0.0903 0.4645 0.0021
0.0318 0.0805 0.4623 0.0003
0.1642 0.2330 0.4520 0.0152
0.1170 0.2453 0.4526 0.0092
0.1617 0.2232 0.4504 0.0121
0.2261 0.0853 0.4557 0.0295
fold, downregulated <0.5 fold; P < 0.05) are shown.
urs after IR.
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Biotechnology, Santa Cruz, California, United States)
overnight at 4°C. After incubation with an Alexa 488-
conjugated donkey anti-rabbit immunoglobulin G (IgG)
antibody (1:500; Molecular Probes, Eugene, United States)
and an Alexa 594-conjugated donkey anti-goat IgG anti-
body (1:500; Molecular Probes), each for two hours at room
temperature, images were captured using a Leica TCS SP2
laser scanning spectral confocal microscope (Leica Micro-
systems, Buffalo Grove, Illinois, United States).
Western blot analysis
The expression of TLR4, TICAM-2, and NF-κB p65 in
spinal cord tissue was determined by western blot ana-
lyses. The rats’ spinal cords were homogenized, and totalFigure 2 Quantitative real-time polymerase chain reaction (qRT-PCR)
were abnormally expressed at both 24 and 72 hours after spinal cord
expression compared to the sham-operated group at either 24 or 72 hou
versus the sham group.proteins were purified using tissue and nuclear protein
extraction reagents according to the manufacturer’s in-
structions (KC-415 and KGP-150; KangChen, Shanghai,
China). The antibodies against TLR4 (1:500; Abcam),
TICAM-2 (1:500; Santa Cruz Biotechnology), and NF-κB
p65 (1:500; Abcam) were used in this experiment, along
with horseradish peroxidase-conjugated secondary anti-
bodies (Bioss, Beijing, China). The scanned images were
semi-quantitated using Quantity One software (Bio-Rad
Laboratories, Milan, Italy).
Measurement of lnterleukin -1β content using ELISA
The spinal cord was collected, homogenized, and then cen-
trifuged. lnterleukin (IL)-1β content was determined with
an ELISA kit (R&D Systems, Minneapolis, Minnesota,analysis confirming the microarray analyses of the nine miRs that
ischemia reperfusion (IR). Relative expression is the change in
rs after reperfusion. Data are expressed as mean ± SEM. **P <0.05
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tions. Absorbance (A) was measured at 450 nm, and the
IL-1β content of each sample was calculated based on a
standard curve and was expressed in pictograms per milli-
gram of total protein.
Statistical analysis
All data were expressed as mean ± standard error of the
mean (means ± SEM) and were analyzed with SPSS soft-
ware (version 17.0; SPSS Inc., Chicago, Illinois, United
States). All variables measured in this study were nor-
mally distributed, and the groups were compared with
Student’s t-test or one-way analysis of variance (ANOVA),
followed by Newman-Keuls post-hoc analysis. A P value
less than 0.05 was considered to be statistically significant.
Results
Aberrant expression of miRs in the spinal cord after
ischemia reperfusion
To determine the potential involvement of miRs in the
spinal cord after IR, we used microarray analysis to de-
termine miR levels in the spinal cord at 24 and 72 hours
after reperfusion. The results showed that compared
with the sham group, in the IR group, three miRs were
upregulated (>2.0 fold) and 15 miRs were downregulated
(<0.5 fold) at 24 hours after surgery (Figure 1a, Table 1),
and four miRs were upregulated (>2.0 fold) and 14 miRs
were downregulated (<0.5 fold) at 72 hours after surgery
(Figure 1b, Table 2).
Nine of the miRs (miR-200b-3p, miR-27a-3p, let-7a-
5p, miR-21-5p, miR-10b-5p, miR-23b-3p, miR-221-3p,
miR-100-5p, and miR-28-5p) were differently expressed
at both 24 and 72 hours after reperfusion. Among them,
miR-27a-3p, let-7a-5p, miR-10b-5p, and miR-23b-3pFigure 3 A putative target site of miR-27a located in the 3′-UTR of TIC
predicted miR-27a binding site in the 3′-untranslated region (UTR) of TICAM
expressed at both 24 and 72 hours after spinal cord ischemia reperfusion (
those of miR-27a. Relative expression is the change in expression compared
Data are expressed as mean ± SEM. **P <0.05 versus the sham group. Resultshave been shown to function as regulators of spinal cord
development and remodeling, and have been implicated
in diseases of the spinal cord [20,21]. Their abnormal ex-
pression was confirmed by quantitative real-time poly-
merase chain reaction (qRT-PCR) (Figure 2). The results
showed that miR-27a was expressed at significantly low
levels after IR and continuously decreased with time
(P < 0.05, versus the sham group). In addition, searching
the TargetScanHuman 6.2 and MicroCosm Targets version
5databases revealed a perfect match to a miR-27a binding
site in the 3′-UTR of the TICAM-2 gene (Figure 3a),
which was confirmed by quantitative real-timeq RT-PCR
(Figure 3b). Therefore, we hypothesized that downregula-
tion of miR-27a might play a role in mediating TLR4-me-
diated secondary inflammatory damage after IR by
up-regulating the TICAM-2 transcript.
Intrathecal pretreatment with an miR-27amimic and anti-miR
oligonucleotides successfully regulated TICAM-2 expression
after ischemia reperfusion
To explore the effects of a synthetic miR-27a mimic
(mimic-27a), miR-27a AMO (AMO-27a), and a negative
control mRNA (NC-27a) on TICAM-2 expression in the
spinal cord after IR, we intrathecally injected mimic-27a,
AMO-27a, and NC-27a for three days before ischemia,
and then examined both the mRNA and protein expres-
sion of TICAM-2 by RT-PCR and western blotting, re-
spectively. As shown in Figure 4a, b, c, compared with
the negative control (NC-27a), intrathecal injection with
mimic-27a significantly prevented the IR-induced in-
creases in TICAM-2 mRNA and protein expression at
24 and 72 hours after reperfusion, whereas injection
with AMO-27a reversed these effects (P < 0.05 versus
the NC-27a group). Compared to the IR group,AM-2 mRNA was predicted by bioinformatics analysis. (a) The
-2 in rats. (b) PCR analysis confirming TICAM-2 mRNA was abnormally
IR). The profiles of TICAM-2 were expressed in an opposite manner as
to the sham-operated group at either 24 or 72 hours after reperfusion.
shown are representative data from three separate experiments.
Figure 4 Effects of intrathecal injection of mimic-27a and AMO-27a on the expression of TICAM-2 and the TLR4/NF-κB/IL-1β pathway in
rats after spinal cord ischemia reperfusion (IR). (a) Representative immunoblots were probed with antibodies against TICAM-2, TLR4, and
nuclear NF-κB p65, and an antibody against GAPDH served as a loading control. (b–g)Quantification of the densities of the TICAM-2 (b), TLR4
(d), and NF-κB p65 (f) bands in nuclear extracts under different conditions. Protein expression is presented in relative units. Real-time PCR
analyses of TICAM-2 (c), TLR4 (e), and NF-κB p65 (g) were performed in duplicate and normalized to GAPDH mRNA levels. (h) Quantification of
IL-1β production in the spinal cord at 24 and 72 hours after IR injury, as assessed by ELISA. IR caused significant increases in TICAM-2 expression,
and intrathecal injection of mimic-27a and AMO-27a altered TICAM-2 expression after IR. In accordance with the decreased TICAM-2 expression,
increased miR-27a levels induced by intrathecal injection of mimic-27a also prevented the increases in TLR4 and nuclear NF-κB p65 expression, as well
as the increased IL-1β levels, whereas suppression of miR-27a by treatment with AMO-27a reversed the above changes, indicating that the TLR4/NF-κB/
IL-1β pathway is involved in the miR-27a-mediated regulation of inflammation in the spinal cord through TICAM-2 targeting. All data are presented as
mean ± SEM. **P <0.05 versus the sham group; ##P <0.05 versus the IR group.
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no obvious differences at 24 and 72 hours after reperfu-
sion (P > 0.05 versus the IR group).
Expression and colocalization of TLR4 and TICAM-2 after
ischemia reperfusion
TICAM-2 is a cytoplasmic protein that is known to be
associated with TLR4 signaling. The relationship between
TICAM-2 and TLR4 expression in the spinal cord 24
and 72 hours after reperfusion was examined by double
immunofluorescence staining. As shown in Figure 5a,
the level of membrane-bound TLR4 immunostaining was
similar to that of cytoplasmic TICAM-2 immunostaining
in the neurons and glial cells of injured spinal cords, but
not in sham-operated ones, which confirmed that TLR4was indeed upregulated when TICAM-2 was upregulated
during IR. Quantification of TICAM-2 expression is
shown in Figure 5b (P < 0.05 versus the IR group).
Conversely, compared to the IR group, increased
miR-27a levels by pretreatment with mimic-27a re-
duced TICAM-2 immunoreactivity and the number of
double-labeled cells in lumbar spinal cords during the
72-hour follow-up period. In contrast, much stronger
TICAM-2 immunoreactivity and more double-labeled
cells were detected in the spinal cords of rats pre-
treated with AMO-27a (P < 0.05 versus the IR group).
No significant difference was observed in operated rats
with or without NC-27a treatment at either 24 or
72 hours (P > 0.05 versus the IR group). Quantification
of the double-labeled cells is shown in Figure 5c.
Figure 5 Effects of intrathecal injection of mimic-27a and AMO-27a on the expression and colocalization of TLR4 and TICAM-2 in vivo
after spinal cord ischemia reperfusion (IR). (a) Representative micrographs showing the colocalization of TLR4 (green) and TICAM-2 (Red) at 24
and 72 hours after IR injury. Arrows show their co-localization. Scale bars = 100 μm. (b) Quantification of TICAM-2 immunoreactivity is presented
as the average fluorescence intensity (FI) of three independent experiments. (c) Histogram for the quantification of co-localized cells (cells with
yellow signals). Double fluorescence immunohistochemistry showing that membrane-bound TLR4 has an expression profile that is similar to that
of TICAM-2 in the cytoplasm of neurons and glial cells from injured regions of the spinal cord at 24 and 72 hours after surgery. Increasing the
levels of miR-27a by intrathecal pretreatment with mimic-27a significantly decreased TICAM-2 immunoreactivity after IR and the number of
TICAM-2-TLR4 positive cells, whereas these effects were reversed by intrathecal injection of AMO-27a. All data are presented as mean ± SEM.
**P <0.01 versus the sham group; ##P <0.05 versus the IR group.
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blood-spinal cord barrier (BSCB) leakage after ischemia
reperfusion
EB content and fluorescent dye were used to assess
IR-induced BSCB disruption as described previously
[6,7,22]. BSCB permeability was visualized by EB ex-
travasation. As shown in Figure 6a, compared with
the sham group, IR caused a marked increase in EB
extravasation at 24 and 72 hours after reperfusion
(P < 0.05 versus the sham group). Intrathecal infusion
of mimic-27a attenuated BSCB dysfunction, as evi-
denced by the decreased EB extravasation and fluores-
cent dye content at 24 and 72 hours after reperfusion,
whereas intrathecal infusion of AMO-27a synergistic-
ally exacerbated BSCB leakage (P < 0.05 versus the IR
group). There were no detectable differences in EB
extravasation between the IR group and the group
pretreated with NC-27a at all time points (P > 0.05).
The quantification of EB content in the spinal cord
shown in Figure 6b and the fluorescent densities
shown in Figure 6c confirmed the above results.Figure 6 Effects of intrathecal injection of mimic-27a and AMO-27a on b
(IR). (a) Effects of intrathecal injection of mimic-27a and AMO-27a on BSC
red fluoresce was seen in the spinal cord of the sham group at 24 and 72
was significantly lower in rats who received an intrathecal injection of mi
fluorescence, especially in the gray matter, was seen in rats who received
72 hours post-injury. (b) The EB content of the spinal cord (μg/g). (c) Quant
100×; Scale bar = 50 μm. **P <0.05 versus the sham group; ##P <0.05 versus thIntrathecal pretreatment with mimic-27a inhibited TLR4/
NF-κB/IL-1β activation after ischemia reperfusion
To further confirm that miR-27a is involved in TLR4
activation by regulating the expression of TICAM-2 after
IR, we examined the mRNA and protein levels of TLR4,
NF-κB, and the downstream inflammatory cytokine
IL-1β by ELISA. In agreement with the double immuno-
fluorescence TICAM-2 and TLR4 staining, intrathecal
pretreatment with mimic-27a reduced the IR-induced
TLR4 and NF-κB mRNA and protein levels at 24 and
72 hours after reperfusion (Figure 4a, d, e, f; P < 0.05
versus the IR group). In contrast, intrathecal infusion of
AMO-27a increased TLR4 and NF-κB mRNA and protein
levels (P < 0.05 versus the IR group) at all time points.
Compared to the IR group, there were no detectable differ-
ences in TLR4 and NF-κB expression when animals were
pretreated with NC-27a (P > 0.05). Furthermore, levels
of the downstream inflammatory cytokine IL-1β also
increased with TLR4 and NF-κB increasing (Figure 4h;
P < 0.05 versus the IR group). These results are consist-
ent with the hypothesis that the IR-mediated reductionlood-spinal cord barrier (BSCB) integrity after ischemia reperfusion
B permeability measured by Evans blue (EB) extravasation. Almost no
hours after IR. Compared with the IR group, EB extravasation (red)
mic-27a. Conversely, at 24 hours after injury, much more red
an intrathecal injection of AMO-27a, which was even stronger at
ification of EB fluorescence density (INT/mm2) . Original magnification,
e IR group.
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in turn influences TLR4 signaling and the activation of
downstream inflammatory cytokines.
Discussion
The BSCB is a physical and biochemical barrier between
the circulation and the spinal cord that plays an important
role in the regulation of spinal cord homeostasis. Disrup-
tion of BSCB integrity after IR injury has been reported to
trigger alterations in the spinal microenvironment, allow-
ing penetration of both inflammatory cytokines and im-
mune cells into the spinal cord, which determines the
prognosis of patients with IR injury [6,7,22]. Accumulating
evidence indicates that some of the major effectors in this
inflammatory damage to BSCB are engagement with toll-
like receptors (the TLRs) signal pathway [5-8,23]. Recently,
many studies have shown that individual miRs, endogen-
ous, non-coding, single-stranded, small RNAs that are
widespread in eukaryotic organisms, are capable of affect-
ing numerous target mRNAs and effectively regulating
their gene expression [8,15,18,19]. Altering the expression
of miRs greatly affects the pathogenesis of IR and its func-
tional outcome [16,24]. Therefore, in this present study, we
provide evidences that miRs attenuate BSCB permeability,
and our findings expand the understanding of the molecu-
lar mechanisms underlying TLR4-mediated inflammatory
responses. To the best of our knowledge, this is the first
study to document a miR-27a target related to the TLR4
pathway in spinal cord IR injury.
MiRs are a class of sophisticated gene expression
regulators with the unique ability to prevent the trans-
lation of and/or degrade their corresponding target
mRNAs by inhibiting translation and promoting cleav-
age, respectively. MiRs act as key regulators in a wide
variety of biological processes, including cell proliferation,
differentiation, apoptosis, and organ development, and
have also been implicated in inflammatory diseases [25,26].
Previous studies showed that some miRs may regulate
genes associated with TLR signaling pathways; the mRNA
expression of five adaptor and interacting proteins
(CD14, HSPA1a, Pglyrp-1, MD-1, and TICAM-2) were
significantly upregulated following traumatic brain in-
jury (TBI) [8,23]. In this study, using a miRs microarray
screening approach, we found that miR-27a expression was
significantly altered at both 24 h and 72 hours after
IR, and such results were as confirmed by qRT-qPCR
(Figure 2).
In animals, recognition of miR response elements only
requires a continuous 6six-base pair ‘“seed match”’ near
the 3′-UTR of its target mRNA [27]. Given this, many
target genes of miR-27a have been identified, some of
which were showed to participated in innate immune re-
sponse and inflammatory responses [28-31]. Whether
miR-27a specifically target TICAM-2 in vivo remainsedto be tested. It hasis recently been shown that pretreat-
ment with miR mimics and AMOs was is one of the
most common and useful methods to regulate the ex-
pression levels of miRs [16,17,28,29]. He et al. reported
that injecting miR mimics 48 hours before IR greatly
downregulated the levels of apoptosis-related genes,
whereas injecting the corresponding AMOs upregu-
lated their expression [17]. Our in vivo data, shown in
Figure 4a, b, c, are in close accordance with previous
studies, showing that compensating for decreased miR-
27a levels by continuous intrathecal injection of mimic-
27a into the subarachnoid space of IR model rats, reduced
the mRNA and protein expression of TICAM-2 by inhi-
biting the translation and/or promoting the degradation of
its mRNA. Continuous intrathecal injection of AMO-27a
before ischemia clearly abrogated reversed such changes.
However, no obvious changes were detected when model
animals were pretreated with NC-27a, suggesting that
miR-27a directly modulates TICAM-2 expression in vivo,
and that modulation of miR-27a is particularly important
in the pathophysiology of IR.
TICAM-2 is a cytoplasmic protein that structurally
resembles the MAL/TIRAP adaptor that links TLR4 and
MyD88 and functionally transmits TLR4 signaling to
TICAM-1 [9,32]. Given the bridging action between TLR4
and TRIF, TICAM-2 coordinates the inflammatory re-
sponse to a pathogen challenge [33]. Thus, it is easy to
postulate that IR-induced aberrant TICAM-2 expression
might be closely associated with TLR4 activation, subse-
quent NF-κB relocation to the nucleus, and the release of
downstream proinflammatory cytokines [9,32,34]. Con-
sistent with this, here, we observe that TLR4 expression is
also significantly upregulated when TICAM-2 expression
increased and miR-27a decreased at both 24 and 72 hours
after IR (Figure 4a, b, c, d, e). In addition, the double
immunofluorescence staining in Figure 5 shows that the
signal for TLR4, a membrane-bound receptor, is greatly
upregulated coincident along with increased cytoplas-
mic staining of TICAM-2 in neuronal and glial cells of
ischemic spinal cords. Therefore, treatments that de-
crease TICAM-2 and inhibit the inflammatory stimula-
tion of TLR4 might be a novel intervention for IR
[9,32,33,35]. We then identifiedy the mechanism under-
lying miR-dependent regulation of TICAM-2 expres-
sion. Intrathecal injection of mimic-27a prevented the
increase in TICAM-2 immunoreactivity and the num-
ber of double-labeled cells, whereas intrathecal injection
of AMO-27a reversed these effects. In accordance with
these observed effects of mimic-27a and AMO-27a on
TICAM-2, we observed similar expression profiles for
TLR4, NF-κB, and the proinflammatory cytokine IL-1β
at 24 and 72 hours post-injury, providing direct evi-
dence that IR-induced TLR4 activation is significantly
influenced by the expression of TICAM-2.
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in the immune system that have been implicated in al-
terations of BSCB integrity [6,7,36,37]. Breakdown of
the BSCB allows exogenous pathogens and circulating
immune cells to enter the spinal cord, which has nu-
merous consequences, including neuronal loss, central
sensitization, and glial remodeling [22,36]. Inhibiting
inflammatory damage to the BSCB has been postulated
as thea key to protection in IR. Our present study pro-
vides clear evidence for the protective effects of specif-
ically increasing miR-27a expression. An Iinjection of
mimic-27a attenuated BSCB dysfunction, which was man-
ifested as reduced fluorescent dye and EB extravasation,
and was suppressed by the injection of AMO-27a; this
finding indicatesd that miR-27a regulates inflammatory
damage to the BSCB by targeting the TICAM-2 mRNA
and the TLR4/NF-κB/IL-1β pathway.
Significantly, one major character of miRs is that a
single miR is capable of regulating the expression of many
target genes, whereas a target gene can also be regulated
by several miRs [11,13,26]. Thus, it is very possible to gain
different or even contradictory expressions when explor-
ing the same miR in differently experimental conditions
[20,28,38,39]. For example, in the recsent study of Young
et al. showed the opposite role of miR-27a in the regula-
tion of vascular leaking by targeting vascular endothelium
(VE)-cadherin in the endothelium [38]. On the other
hand, some studies showed an upregulation of miR-27a
for systemic inflammation, instead of the down-regulation
as described in this study in the event of systemic inflam-
mation [28,39]. These disagreements might be caused by
the different observation time points, which are consistent
with the descriptions of that no changes being observed in
miR-27a expression for at 6 hours, instead of downregula-
tion for at 24 hours after lipopolysaccharide (LPS) treat-
ments [28]. Moreover, the net effects of miRs observed in
in vivo experiments were also influenced by the compli-
cated internal environment [20,40]. Luxenhofer G et al.
emphasized the importance of miRs in regulating the mo-
lecular network specifying the generation of neuronal
diversity in the developing chick spinal cord [40]. Ziu M
et al. also showed significantly different expression levels
of miRs in prolonged compression injury compared to
those in short compression injury [20]. Furthermore, dif-
ferent expressions of miRs were reported in different re-
gions of the injured spinal cord, even under the same
experimental conditions [20]. Thus, aseptically inflamma-
tory responses during spinal cord IR injury could not be
exactly equivalent to directly proinflammatory stimuli
with LPS in vitro as well as the results obtained from the
lung tissue. Further in vitro and in vivo studies still need
to be conducted to identify the correlation between
miR-27a and the corresponding target genes in the
mode of inflammatory or anti-inflammatory actions tobetter elucidate the mechanism and provide potential
therapeutic targets for IR.
Taken together, we identify TICAM-2 as a novel tar-
get of miR-27a and show that downregulation of miR-
27a promotes IR-induced inflammatory damage to the
BSCB by facilitating activation of the TLR4/NF-κB/IL-1β
signaling pathway.
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